65 results for "Yashdeep Gupta"
Showing 1–20 · 0.89 seconds · RSS
-
Journal Article
Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment
Glucocorticoid-induced myopathy is the most common type of drug-induced myopathy. Nearly 60% of patients with Cushing′s syndrome have muscle weakness. Glucocorticoid-induced muscle atrophy affects mainly fast-twitch glycolytic muscle fibers (type IIb fibers). This brief review will discuss the…
-
Journal Article
Continuous subcutaneous insulin infusion versus multiple dose insulin
Continuous subcutaneous insulin infusion (CSII), also known as insulin pump therapy and multiple dose insulin (MDI) are the two main intensified insulin regimens that have been used to achieve strict glycaemic control in patients with diabetes mellitus, especially with type 1 diabetes (T1DM). Each…
-
Journal Article
Insulin technique
Insulin is an important treatment modality of treating diabetes and insulin technique; is a vital component of the insulin prescription and of diabetes care. A thorough knowledge regarding insulin preparations, devices, injecting techniques and the problems encountered with insulin use are…
-
Journal Article
Essential Medicines for Children: An Endocrine Perspective
The emergence of endocrine disease has created significant challenges for healthcare policy-makers and payers across the world. Policy-makers have to ensure availability of drugs used for various endocrinopathies. One way in which this is facilitated is through the World Health Organization (WHO)…
-
Journal Article
Vitiligo, hypothyroidism and cardiomyopathy
Vitiligo in association with autoimmune endocrine disorders, especially with hypothyroidism, is not uncommon. Some amount of pericardial effusion is usually present in long-standing/untreated hypothyroidism. Here we describe the case of young male with, long-standing progressive vitiligo…
-
Journal Article
Insulin-derived amyloidosis
Amyloidosis is the term for diseases caused by the extracellular deposition of insoluble polymeric protein fibrils in tissues and organs. Insulin-derived amyloidosis is a rare, yet significant complication of insulin therapy. Insulin-derived amyloidosis at injection site can cause poor glycemic…
-
Journal Article
Sodium-glucose cotransporter-2 inhibition and the insulin: Glucagon ratio: Unexplored dimensions
The sodium-glucose cotransporter 2 (SGLT-2) inhibitors are a novel class of glucose-lowering drugs which act by inhibiting the reabsorption of filtered glucose from the kidneys. Their effect on insulin and glucagon levels has recently been studied but is not fully explained. This communication…
-
Journal Article
Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
Sodium glucose transporter 2 (SGLT2) inhibitors are a recently developed class of drug that have been approved for use in type 2 diabetes. Their unique extra-pancreatic glucuretic mode of action has encouraged their usage in type 1 diabetes as well. At the same time, reports of pseudo ketoacidosis…